Research Associate II/Senior Research Associate, Analytical Development
TLDR
Develop and qualify assays for transgene expression in genetically modified porcine cells using primary cell culture, flow cytometry, ELISA, and PCR.
About eGenesis
eGenesis is a clinical-stage biotechnology company developing human-compatible engineered organs to address the severe global organ shortage. The Company’s proprietary genome engineering platform enables extensive, multiplex gene edits to remove key biological barriers, add protective human transgenes, and inactivate endogenous retroviruses. EGEN-2784, a genetically engineered porcine kidney, is the Company’s lead program and is currently being evaluated in a multi-patient Expanded Access study at MGH. eGenesis is headquartered in Cambridge, MA.
POSITION SUMMARY
We are seeking a highly motivated individual to join the Analytical Development team as a Research Associate II / Senior Research Associate. This position is an excellent opportunity to help develop new gene editing and xenotransplantation products in an exciting and dynamic environment focused on cutting-edge molecular and cellular engineering technology.
In this role, you will be part of a small team responsible for developing and qualifying methods to assess transgene expression and function in genetically modified porcine cells. This role will involve significant cell culture work, including the isolation, growth and maintenance of primary cells, such as endothelial cells from various porcine organs, and characterizing these cells using techniques such as flow cytometry, ELISA, and PCR. To be successful in this role, you will leverage previous experience with immunological and genomic assays. This role is a full-time lab-based position in which being proactive, determined, responsible, coachable, and collaborative will help you thrive.
PRIMARY RESPONSIBILITIES
QUALIFICATIONS
The base salary range for this position is $80,000 - $98,000.
eGenesis develops innovative genome engineering technologies aimed at providing safe and effective organ solutions for patients facing organ failure. Our focus is on creating alternatives that can make organ transplants more accessible and reliable, significantly improving patients' quality of life.
- Founded
- Founded 2015
- Employees
- 51-200 employees
- Total raised
- $140M raised